Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Wednesday - 28 April 2021

Wednesday, 28 April 2021

Questions (1085)

Jennifer Whitmore

Question:

1085. Deputy Jennifer Whitmore asked the Minister for Health if he will publish the review conducted on the cost effectiveness of flash glucose monitoring technology for those with type 1 diabetes; if he will consider making this technology available for all persons in Ireland with type 1 diabetes; and if he will make a statement on the matter. [22236/21]

View answer

Written answers

The review referred to by the Deputy was undertaken by the HSE. Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Question No. 1086 answered with Question No. 916.
Question No. 1087 answered with Question No. 914.
Top
Share